
Laxmi Dental Limited
Laxmi Dental Limited(LAXMIDENTL)
Total Shares
1,63,09,766
Issue Size
₹698.06 Cr
Price Band
₹407 – ₹428
Lot Size
33 shares
Min. Investment
₹14,124
Max. Investment
₹14,124
Open Date
13 Jan, 2025
Close Date
15 Jan, 2025
Allotment
16 Jan, 2025
Listing
20 Jan, 2025
Max. Investment
₹14,124
Announced
13 Jan, 2025
Opening Date
13 Jan, 2025
Closing Date
15 Jan, 2025
Basis of Allotment
16 Jan, 2025
Initiation of Refunds
17 Jan, 2025
Credit of Shares
17 Jan, 2025
Listing Date
20 Jan, 2025
Live GMP
Est. Listing: ₹549
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Laxmi Dental Limited IPO
Incorporated in July 2004, Laxmi Dental Limited is an integrated dental products company. The company offers custom crowns and bridges, branded dental items like clear aligners and thermoforming sheets, aligner-related products as part of its aligner solutions, and pediatric dental products.
Their product portfolio includes custom crowns and bridges, clear aligners, thermoforming sheets, pediatric dental products, and more.
The company offers thermoforming sheets, biocompatible
Laxmi Dental Limited IPO Share Price and Issue Size
Issue Breakdown
Shareholding
Laxmi Dental Limited IPO Financials Health
Laxmi Dental Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| SHNI Maximum | 70 | 2310 | ₹9,88,680 |
| BHNI Minimum | 71 | 2343 | ₹10,02,804 |
| Retail Minimum | 1 | 33 | ₹14,124 |
| Retail Maximum | 14 | 462 | ₹1,97,736 |
| SHNI Minimum | 15 | 495 | ₹2,11,860 |
(All values in CR)
Laxmi Dental Limited IPO Valuation
| Metric | Value |
|---|---|
| DEBT/EQUITY | 0.94 |
| EPS Post IPO | 8.27 |
| EPS Pre IPO | 4.88 |
| P/E Post IPO | 51.73 |
| P/E Pre IPO | 87.77 |
| PAT MARGIN | 13.03 |
| PRICE TO BOOK VALUE | 49.59 |
| ROCE | 19.97% |
| ROE | 78.78% |
| RONW | 78.78% |
(All values in CR)
Strength & Risk of Laxmi Dental Limited IPO
1. The only integrated dental products company in India, well-positioned to capture industry tailwinds.
2. Second largest player in domestic laboratory business and largest export laboratory with increasing adoption of digital dentistry.
3. Vertically integrated diverse branded product portfolio.
4. Large Dental Network providing us with competitive advantage in the market.
5. Robust technologically advanced capabilities with stringent regulatory compliance ensuring high quality standards.
6. Experienced management team with significant industry experience.
1. The Company has reported consolidated loss after tax, negative earning per share for Fiscals 2023 and 2022, and written off Assets in last three Fiscals and its cannot assure that the company will not experience such events in the future.
2. Its Statutory Auditors have included an emphasis of matter in their auditor's report on its audited financial statements as at and for the Financial Year ended 2024 and 2023.
3. Its business success depends on expanding the company Dental Network, recommendations by its Dental Network and increasing the wallet share per dental clinic, dental company and dentist. Failures to achieve this in a cost-effective manner could have an adverse effect on its business, results of operations and financial condition.
4. The company's business is concentrated in certain jurisdictions, globally and domestically, and any loss of business in such regions could have an adverse effect on its business, results of operations and financial condition.
5. There are outstanding legal proceedings involving the Company, Subsidiaries, Promoters, and Directors which could have an adverse effect on its business, financial condition and results of operations.
6. The company's business depends heavily on its reputation and perception of the company brands. Any negative publicity or other harm to its brand or failures to maintain and enhance the company brand recognition and maintain such quality standards may materially and adversely affect its reputation, business, results of operations and financial condition.
7. All its major manufacturing facilities are situated in and around Mumbai and any disruptions in the region could have a material and adverse effect on its business, financial condition and results of operations.
8. Import and Exports are material to its business operation. Further, a failures to manage the company business in overseas markets or its inability to grow the company business in new geographic markets may affect its growth, which could have a material adverse effect on its business, operations, prospects or financial condition.
9. Its inability to effectively manage the company growth or to successfully implement its business plan and growth and expansion strategy could have an adverse effect on the company business, results of operations and financial condition.
10. There is an outstanding legal proceeding involving its Promoter, Chairperson and Whole-time Director. Any adverse decision in such proceeding could have an adverse effect on its business, financial condition and results of operations.
Laxmi Dental Limited IPO Subscription Status
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 73,39,395 | 73,39,395 | 314.13 |
| BHNI (10L+) | 167.68 | 16,30,977 | 27,34,89,216 | 11 |
| HNI | 147.51 | 24,46,465 | 36,08,86,152 | 15 |
| QIB | 110.38 | 48,92,929 | 54,00,81,366 | 23 |
| Retail | 74.43 | 16,30,977 | 12,13,87,926 | 5 |
| SHNI (2L - 10L) | 107.17 | 8,15,488 | 8,73,96,936 | 3 |
| Total | 113.97 | 89,70,371 | 1,02,23,55,444 | 43 |
Laxmi Dental Limited IPO GMP
Last updated 08 Jan, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 08 Jan, 2025 | 428 | ₹121▼ | 3000/45000 | ₹549 (28.27%) | - | 08 Jan, 2025 |
| 09 Jan, 2025 | 428 | ₹165▲ | 4100/61500 | ₹593 (38.55%) | - | 09 Jan, 2025 |
| 10 Jan, 2025 | 428 | ₹163 | 4100/61500 | ₹591 (38.08%) | - | 10 Jan, 2025 |
| 11 Jan, 2025 | 428 | ₹163▲ | 4100/61500 | ₹591 (38.08%) | - | 11 Jan, 2025 |
| 13 Jan, 2025 | 428 | ₹142 | 3600/54000 | ₹570 (33.18%) | - | 13 Jan, 2025 |
| 14 Jan, 2025 | 428 | ₹142▲ | 3600/54000 | ₹570 (33.18%) | - | 14 Jan, 2025 |
| 15 Jan, 2025 | 428 | ₹126▲ | 3200/48000 | ₹554 (29.44%) | - | 15 Jan, 2025 |
| 16 Jan, 2025 | 428 | ₹120▲ | 3000/45000 | ₹548 (28.04%) | - | 16 Jan, 2025 |
| 17 Jan, 2025 | 428 | ₹101▼ | 2500/37500 | ₹529 (23.60%) | - | 17 Jan, 2025 |
| 18 Jan, 2025 | 428 | ₹143▼ | 3600/54000 | ₹571 (33.41%) | - | 18 Jan, 2025 |
| 20 Jan, 2025 | 428 | ₹145 | 3600/54000 | ₹573 (33.88%) | - | 20 Jan, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Laxmi Dental Limited IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Laxmi Dental Limited under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.